US Biologic® to Present Development of a Chewable Flu Vaccine: Offers New Tool to Increase Vaccine Equity, Avoid Needles, and Reduce Pandemics

/PRNewswire/ -- US Biologic, a leading global entity in the development, commercialization, and distribution of orally delivered vaccines, announced today that...

Related Keywords

United States ,America ,Mason Kauffman ,David Sanders ,Centers For Disease ,Biomedical Advanced Research ,Development Authority ,International Conference On Vaccines Research Development ,Division Of Research ,Chief Scientific Officer ,International Conference ,Vaccines Research ,Boston Marriott Newton ,Vaccination Strategies ,Pandemic Prevention ,Disease Control ,Executive Director ,Securing America ,Us Biologic ,